2025 ACIP Immunization Schedules

News
Article
Drug Topics JournalDrug Topics January/February 2025
Volume 169
Issue 01

More detailed information can be found on the CDC’s website at www.cdc.gov/vaccines.

Another new year means another update to the CDC’s Advisory Committee on Immunization Practices (ACIP) immunization schedules.1 In 2024, ACIP made a number of changes to vaccine recommendations, including a new 21-valent pneumococcal conjugate vaccine, new respiratory syncytial virus vaccines for adults and pregnant women, and more.

The following tables have been created using the CDC’s recommended immunization schedules for 2025.

To read these stories and more, download the PDF of the Drug Topics January/February issue here.

Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips? Sign up today for our free Drug Topics newsletter.

Reference
Immunization schedules. CDC. November 21, 2024. Accessed January 27, 2025. https://www.cdc.gov/vaccines/hcp/imz-schedules/index.html
Download Issue PDF
Articles in this issue
2025 ACIP Immunization Schedules
2025 ACIP Immunization Schedules
New Drug Review: FDA Approves Tryvio for the Treatment of Hypertension in Combination With Other Antihypertensive Drugs to Lower Blood Pressure
New Drug Review: FDA Approves Tryvio for the Treatment of Hypertension in Combination With Other Antihypertensive Drugs to Lower Blood Pressure
OTC Roundup: Digestive Health Products
OTC Roundup: Digestive Health Products
Q&A: The Pharmacist’s Ability to Provide Nutritional Guidance
Q&A: The Pharmacist’s Ability to Provide Nutritional Guidance
FDA Requires Abrysvo, Arexvy RSV Vaccine Labels to Include Guillain-Barré Warning
FDA Requires Abrysvo, Arexvy RSV Vaccine Labels to Include Guillain-Barré Warning
Mediterranean, DASH Remain Supreme Among Other Dietary Regimens
Mediterranean, DASH Remain Supreme Among Other Dietary Regimens
Q&A: Challenges, Barriers Impacting Glucagon Prescribing
Q&A: Challenges, Barriers Impacting Glucagon Prescribing
Examining Impact of Continuous Glucose Monitors on Diabetes | ASHP Midyear
Examining Impact of Continuous Glucose Monitors on Diabetes | ASHP Midyear
Q&A: Educating Patients, Providers to Increase Biosimilar Implementation | ASHP Midyear
Q&A: Educating Patients, Providers to Increase Biosimilar Implementation | ASHP Midyear
Q&A: Importance of Managing Comorbidities for Patients with MASLD | ASHP Midyear
Q&A: Importance of Managing Comorbidities for Patients with MASLD | ASHP Midyear
Q&A: Statin, Nonstatin Combination Therapy to Treat Patients’ Cardiovascular Risk | ASHP Midyear
Q&A: Statin, Nonstatin Combination Therapy to Treat Patients’ Cardiovascular Risk | ASHP Midyear
In A Warming World, Climate-Resilient Health Care Delivery Is Key | ASHP Midyear
In A Warming World, Climate-Resilient Health Care Delivery Is Key | ASHP Midyear
HIV Treatment, PrEP Have Come a Long Way, With More Work To Be Done | ASHP Midyear
HIV Treatment, PrEP Have Come a Long Way, With More Work To Be Done | ASHP Midyear
Pharmacist-Led Care Leads to Better Outcomes in ASCVD | ASHP Midyear
Pharmacist-Led Care Leads to Better Outcomes in ASCVD | ASHP Midyear
Navigating Cannabis Use in Health Care Settings | ASHP Midyear
Navigating Cannabis Use in Health Care Settings | ASHP Midyear
Recent Videos
Related Content
Expert: For Every 1 Measles Case, There Are Expected to Be 12 to 18 More

Expert: For Every 1 Measles Case, There Are Expected to Be 12 to 18 More

Ashley Gallagher;Crystal Hodge, PharmD
April 18th 2025
Article

Crystal Hodge discusses R naughts and the measures of how contagious measles is.

pharmacist holds prescription packet

Good Neighbor Pharmacy Customers Across the US Reflect and Look Forward

September 20th 2021
Podcast

Good Neighbor Pharmacy customers from rural, suburban, and city areas reflect on the past year and discuss the future of independent pharmacy.

ACIP Votes to Expand RSV Vaccine Recommendation to Include Adults 50 Years and Older

ACIP Votes to Expand RSV Vaccine Recommendation to Include Adults 50 Years and Older

Ashley Gallagher
April 17th 2025
Article

Currently, the recommendation is for patients 75 years and older and those aged 60 to 74 years with an increased risk of severe respiratory syncytial virus.

ACIP Votes to Recommend the Use of MenABCWY in Adolescent Vaccine Schedule

ACIP Votes to Recommend the Use of MenABCWY in Adolescent Vaccine Schedule

Ashley Gallagher
April 17th 2025
Article

The FDA approved Penmenvy in February 2025 for use in patients aged 10 to 25 years.

PPSV23 Decreased Sinusitis, Antibiotic Use in Pediatric Patients

PPSV23 Decreased Sinusitis, Antibiotic Use in Pediatric Patients

Brian Nowosielski
April 11th 2025
Article

Researchers explored the association of a pneumococcal polysaccharide vaccine booster and health care utilization in children with sinusitis and low pneumococcal antibody titers.

FDA Grants Fast Track Designation for Potential Bird Flu Vaccine

FDA Grants Fast Track Designation for Potential Bird Flu Vaccine

Ashley Gallagher
April 11th 2025
Article

The designation addresses the unmet need for prevention of H5N1, which remains a global health risk, and a phase 1 trial of the vaccine was initiated in November 2024.

© 2025 MJH Life Sciences

All rights reserved.